Governance Board

Our Governance Board is responsible for determining the strategic direction of the Centre and monitoring its progress. Its aims are:

  • To develop the overall strategy of the Centre.
  • To monitor the progress of the Centre against its strategic objectives.
  • To oversee the operation of the Centre, providing links between all the partner organisations.
  • To monitor the allocation of funding within the Centre, ensuring that this is equitable and in line with the strategy of the Centre.
  • To review and respond to initiatives put forward by Cancer Research UK and other funding bodies.

Current Board Members

Anna Dominiczak Chair, Head, College of Medical, Veterinary & Life Sciences, University of Glasgow
Stan Kaye Deputy Chair, Institute of Cancer Sciences, London
Andrew Biankin Director, Wolfson Wohl Translational Cancer Research Centre, University of Glasgow
Julie Brittenden Director, NHS R&D
David Dodds Clinical Director, Beatson West of Scotland Cancer Centre
Jeff Evans Director, Institute of Cancer Sciences, University of Glasgow
Gerry Graham Deputy Director, Institute of Infection, Immunity & Inflammation, University of Glasgow
Tessa Holyoake Director, Paul O’Gorman Leukaemia Research Centre, University of Glasgow (Management Board representative)
David Littlejohn Executive Dean, Faculty of Science, University of Strathclyde
Gary Jenkins Director, Regional Services, NHS Greater Glasgow & Clyde
Simon Mackay Professor of Medicinal Chemistry, University of Strathclyde
Iain McNeish Chair of Gynaecological Oncology, University of Glasgow (Management Board representative)
Liz Musgrove Synergy Manager, Institute of Cancer Sciences, University of Glasgow
Owen Sansom Interim Director, Cancer Research UK Beatson Institute
David Scott Director, Discovery Research & Centres, Cancer Research UK